Published in Lab Law Weekly, August 27th, 2004
The company has also filed for protection for the invention titled "Intracellular Generation of Single-stranded DNA" under national phase PCT filings in 12 countries, including France, Germany, Switzerland, China, India, and Israel, and the company received a publication date for the PCT application filed for the invention titled "Treatment of HSV-Related Pathologies Using ssDNA."
Malcolm Skolnick, president and CEO of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.